Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 118.51 +2.35 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.16 | 52 Week High | $39.41 | |||
| Open | $115.50 | 52 Week Low | $25.98 | |||
| Day High | $119.20 | P/E | 166.92 | |||
| Day Low | $115.49 | EPS | $0.71 | |||
| Volume | 777,377 | |||||
